Toronto aortic stenosis quality of life questionnaire (TASQ): validation in TAVI patients.
Aged
Aged, 80 and over
Aortic Valve Stenosis
/ diagnosis
Female
Humans
Male
Patient Reported Outcome Measures
Predictive Value of Tests
Psychometrics
Quality of Life
Recovery of Function
Reproducibility of Results
Time Factors
Transcatheter Aortic Valve Replacement
/ adverse effects
Treatment Outcome
Aortic stenosis
Patient-reported outcome measurement
Quality of life
TAVI
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
05 05 2020
05 05 2020
Historique:
received:
20
11
2019
accepted:
12
04
2020
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
2
12
2020
Statut:
epublish
Résumé
Aortic stenosis (AS) is a common cardiac condition whose prevalence increases with age. The symptom burden associated with severe aortic stenosis (AS) can introduce significant lifestyle disruptions and if left untreated can lead to a poor prognosis. Quality of life (QoL) is an important consideration in these patients. The TASQ is a QoL tool that was developed for aortic stenosis patients. We evaluated the psychometric properties of this specific questionnaire in patients who underwent transcatheter aortic valve implantation (TAVI), which is a therapeutic option for patients with severe aortic stenosis (AS). The properties of the TASQ in measuring QoL were evaluated in AS patients undergoing TAVI. Patients presenting for the TAVI procedure (N = 62) were evaluated pre-TAVI, at discharge, 1-month, and 3-month follow-ups. Demographic information as well as caregiver status, and daily activities were recorded. In addition to the TASQ, they completed the KCCQ (Kansas City Cardiomyopathy Questionnaire) and the IIRS (Illness Intrusiveness Rating Scale). The TASQ is a 16-item self-administered questionnaire that assesses AS-specific QoL across five domains: physical symptoms; physical limitations; emotional impact; social limitations, and health expectations. TASQ subscales are internally consistent (α = 0.74-0.96) and showed significant improvements from baseline across assessments (p < 0.001). Construct validity evidence was demonstrated by correlations consistent with theoretically derived hypotheses across time points. The TASQ is a brief measure of AS-specific QoL that is sensitive to change in patients undergoing TAVI. Items on the TASQ capture important QoL concerns reported by AS patients, suggesting this is a measure of relevant and meaningful outcomes for this patient population. Detection of early improvements in QoL by the TASQ is promising, with important implications for the evaluation of procedural outcomes in this population.
Sections du résumé
BACKGROUND
Aortic stenosis (AS) is a common cardiac condition whose prevalence increases with age. The symptom burden associated with severe aortic stenosis (AS) can introduce significant lifestyle disruptions and if left untreated can lead to a poor prognosis. Quality of life (QoL) is an important consideration in these patients. The TASQ is a QoL tool that was developed for aortic stenosis patients. We evaluated the psychometric properties of this specific questionnaire in patients who underwent transcatheter aortic valve implantation (TAVI), which is a therapeutic option for patients with severe aortic stenosis (AS).
METHODS
The properties of the TASQ in measuring QoL were evaluated in AS patients undergoing TAVI. Patients presenting for the TAVI procedure (N = 62) were evaluated pre-TAVI, at discharge, 1-month, and 3-month follow-ups. Demographic information as well as caregiver status, and daily activities were recorded. In addition to the TASQ, they completed the KCCQ (Kansas City Cardiomyopathy Questionnaire) and the IIRS (Illness Intrusiveness Rating Scale).
RESULTS
The TASQ is a 16-item self-administered questionnaire that assesses AS-specific QoL across five domains: physical symptoms; physical limitations; emotional impact; social limitations, and health expectations. TASQ subscales are internally consistent (α = 0.74-0.96) and showed significant improvements from baseline across assessments (p < 0.001). Construct validity evidence was demonstrated by correlations consistent with theoretically derived hypotheses across time points.
CONCLUSIONS
The TASQ is a brief measure of AS-specific QoL that is sensitive to change in patients undergoing TAVI. Items on the TASQ capture important QoL concerns reported by AS patients, suggesting this is a measure of relevant and meaningful outcomes for this patient population. Detection of early improvements in QoL by the TASQ is promising, with important implications for the evaluation of procedural outcomes in this population.
Identifiants
pubmed: 32370791
doi: 10.1186/s12872-020-01477-2
pii: 10.1186/s12872-020-01477-2
pmc: PMC7201733
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
209Subventions
Organisme : Edwards Lifesciences
ID : 410007511
Pays : International
Références
Int J Older People Nurs. 2014 Sep;9(3):227-46
pubmed: 23575032
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
Circ Cardiovasc Interv. 2016 Jun;9(6):
pubmed: 27296201
J Am Coll Cardiol. 2000 Apr;35(5):1245-55
pubmed: 10758967
Int J Behav Med. 2016 Feb;23(1):49-62
pubmed: 26223485
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
JAMA Cardiol. 2017 Apr 1;2(4):409-416
pubmed: 28146260
CMAJ. 2001 Jul 24;165(2):174-9
pubmed: 11501456
Mayo Clin Proc. 2018 Apr;93(4):488-508
pubmed: 29622096
Mayo Clin Proc. 2007 Oct;82(10):1244-54
pubmed: 17908530
J Invasive Cardiol. 2016 Dec;28(12):492-496
pubmed: 27743507
Circ Heart Fail. 2013 Jan;6(1):61-7
pubmed: 23230306
Neth Heart J. 2013 Jan;21(1):21-7
pubmed: 23229811
Ann Cardiothorac Surg. 2012 Jul;1(2):216-9
pubmed: 23977497
Eur Heart J. 2018 Jul 21;39(28):2635-2642
pubmed: 29546396
Eur J Cardiothorac Surg. 2017 May 1;51(5):919-926
pubmed: 28369303
Open Heart. 2019 May 21;6(1):e001008
pubmed: 31218003
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
J Cardiovasc Nurs. 2010 Jan-Feb;25(1):25-39
pubmed: 20134282
J Psychosom Res. 2010 Jun;68(6):591-602
pubmed: 20488277
Circulation. 2011 Nov 1;124(18):1964-72
pubmed: 21969017
Kardiol Pol. 2014;72(7):612-6
pubmed: 24671914
Eur Heart J. 2014 Aug 7;35(30):2001-9
pubmed: 24904027
Ann Fam Med. 2011 Mar-Apr;9(2):100-3
pubmed: 21403134
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):591-7
pubmed: 24021691
Can J Cardiol. 2012 Sep-Oct;28(5):520-8
pubmed: 22703948
Int J Artif Organs. 2016 Oct 10;39(8):444-449
pubmed: 27716868
PLoS One. 2018 May 10;13(5):e0196877
pubmed: 29746546
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
BMJ. 2001 Jun 2;322(7298):1357-60
pubmed: 11387189
Can J Cardiol. 2018 Mar;34(3):330-332
pubmed: 29475532